Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis
暂无分享,去创建一个
Wu Zhu | Guixue Hou | Zhanlong Mei | Chunwei Zeng | Siqi Liu | Xiang Chen | Yehong Kuang | Weiqi Zeng | Juan Su | Siqi Liu | Xiang Chen | Zhanlong Mei | Juan Su | Cong Peng | Jie Li | Lily Lei | C. Peng | B. Wen | Guixue Hou | Xiaomin Chen | Bo Wen | Li Lei | Xuekun Jia | Jie Li | Y. Kuang | Xiaomin Chen | W. Zeng | Wu Zhu | Chunwei Zeng | X. Jia | J. Su
[1] Siqi Liu,et al. metaX: a flexible and comprehensive software for processing metabolomics data , 2017, BMC Bioinformatics.
[2] Jianguo Xia,et al. Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis , 2016, Current protocols in bioinformatics.
[3] N. Arora,et al. Lysophosphatidylcholine plays critical role in allergic airway disease manifestation , 2016, Scientific Reports.
[4] A. Indra,et al. Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans , 2016, Expert review of proteomics.
[5] D. Gladman,et al. The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts , 2016, The Journal of Rheumatology.
[6] Sai-nan Zhu,et al. Characterization of the abnormal lipid profile in Chinese patients with psoriasis. , 2015, International journal of clinical and experimental pathology.
[7] Shan Jiang,et al. Biomarkers of An Autoimmune Skin Disease—Psoriasis , 2015, Genom. Proteom. Bioinform..
[8] A. Kyrgidis,et al. IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity , 2015, Journal of cutaneous medicine and surgery.
[9] G. J. Harry,et al. Autotaxin Downregulates LPS‐Induced Microglia Activation and Pro‐Inflammatory Cytokines Production , 2014, Journal of cellular biochemistry.
[10] M. Huse. Lipid-based patterning of the immunological synapse. , 2014, Biochemical Society transactions.
[11] Giridharan Gokulrangan,et al. Proteomics of Skin Proteins in Psoriasis: From Discovery and Verification in a Mouse Model to Confirmation in Humans* , 2014, Molecular & Cellular Proteomics.
[12] J L Gómez-Ariza,et al. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry. , 2014, Journal of pharmaceutical and biomedical analysis.
[13] André Nadler,et al. Caged lipids as tools for investigating cellular signaling. , 2014, Biochimica et biophysica acta.
[14] M. Ratajczak,et al. Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy , 2014, Molecular Cancer Research.
[15] Elaine Holmes,et al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry. , 2014, Analytical chemistry.
[16] M. Blumenberg. Skinomics: past, present and future for diagnostic microarray studies in dermatology , 2013, Expert review of molecular diagnostics.
[17] M. Huse,et al. From lipid second messengers to molecular motors: microtubule‐organizing center reorientation in T cells , 2013, Immunological reviews.
[18] Christoph Steinbeck,et al. The role of reporting standards for metabolite annotation and identification in metabolomic studies , 2013, GigaScience.
[19] D. A. Foster. Phosphatidic acid and lipid-sensing by mTOR , 2013, Trends in Endocrinology & Metabolism.
[20] David A. Martin,et al. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.
[21] Rosa Parisi,et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.
[22] T. Tsukahara. The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists , 2012, PPAR research.
[23] W. Kong,et al. Fenofibrate Enhances the In Vitro Differentiation of Foxp3+ Regulatory T Cells in Mice , 2012, PPAR research.
[24] R. Coleman,et al. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling , 2012, Proceedings of the National Academy of Sciences.
[25] T. Lotti,et al. Mucosal psoriasis: a new insight toward a systemic inflammatory disease , 2011, International journal of dermatology.
[26] Claudio J. Verzilli,et al. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration , 2011, European heart journal.
[27] Mee-Sup Yoon,et al. Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect* , 2011, The Journal of Biological Chemistry.
[28] Joshua D. Knowles,et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.
[29] Chunyu Liu,et al. Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.
[30] Terry K. Smith,et al. The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine , 2010, IUBMB life.
[31] D. A. Foster. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. , 2009, Biochimica et biophysica acta.
[32] J. Kabarowski. G2A and LPC: regulatory functions in immunity. , 2009, Prostaglandins & other lipid mediators.
[33] A. Morris,et al. Regulation of blood and vascular cell function by bioactive lysophospholipids , 2009, Journal of thrombosis and haemostasis : JTH.
[34] F. Nestle,et al. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.
[35] A. Sheikh,et al. Lysophosphatidylcholine induces glial cell activation: Role of rho kinase , 2009, Glia.
[36] S. Gabriel,et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. , 2009, Arthritis and rheumatism.
[37] Meihong Chen,et al. Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells. , 2008, Biochemical and biophysical research communications.
[38] P. Robin,et al. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin Published, JLR Papers in Press, November 16, 2007. , 2008, Journal of Lipid Research.
[39] R. García-Becerra,et al. Regulation of LPA receptor function by estrogens. , 2008, Biochimica et biophysica acta.
[40] Age K. Smilde,et al. UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation , 2008 .
[41] J. Balsinde,et al. Group V Phospholipase A2-Derived Lysophosphatidylcholine Mediates Cyclooxygenase-2 Induction in Lipopolysaccharide-Stimulated Macrophages1 , 2007, The Journal of Immunology.
[42] J. Lykkesfeldt. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[43] W. Moolenaar,et al. Regulation and biological activities of the autotaxin-LPA axis. , 2007, Progress in lipid research.
[44] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[45] David W. Russell,et al. LMSD: LIPID MAPS structure database , 2006, Nucleic Acids Res..
[46] I. Wilson,et al. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. , 2006, The Analyst.
[47] C. McMaster,et al. Glycerophosphocholine Catabolism as a New Route for Choline Formation for Phosphatidylcholine Synthesis by the Kennedy Pathway* , 2005, Journal of Biological Chemistry.
[48] M. Wenk. The emerging field of lipidomics , 2005, Nature Reviews Drug Discovery.
[49] Li V. Yang,et al. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. , 2005, Blood.
[50] G. Carman,et al. Regulation of Phospholipid Synthesis in the Yeast cki1Δ eki1Δ Mutant Defective in the Kennedy Pathway , 2004, Journal of Biological Chemistry.
[51] G. Carman,et al. Regulation of Phospholipid Synthesis in the Yeastcki1Δeki1Δ Mutant Defective in the Kennedy Pathway: THECHO1-ENCODED PHOSPHATIDYLSERINE SYNTHASE IS REGULATED BY mRNA STABILITY , 2004 .
[52] Chunxiang Zhang,et al. Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation , 2004, The Journal of experimental medicine.
[53] M. Barker,et al. Partial least squares for discrimination , 2003 .
[54] Daniel L Baker,et al. Plasma lysophosphatidic acid concentration and ovarian cancer. , 2002, JAMA.
[55] D. Baker,et al. Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood* , 2002, The Journal of Biological Chemistry.
[56] K. Hirata,et al. Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. , 2001, Biochemical and biophysical research communications.
[57] Y. Shoenfeld,et al. Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis , 1999, Lupus.
[58] Y. Kitajima,et al. Lipocortin I (annexin I) is preferentially localized on the plasma membrane in keratinocytes of psoriatic lesional epidermis as shown by immunofluorescence microscopy. , 1991, The Journal of investigative dermatology.
[59] U. Beuers,et al. Lysophosphatidic acid and signaling in sensory neurons. , 2015, Biochimica et biophysica acta.
[60] A. Gottlieb,et al. Research gaps in psoriasis: opportunities for future studies. , 2014, Journal of the American Academy of Dermatology.
[61] F. Toyoda,et al. Lysophosphatidylcholine enhances I(Ks) currents in cardiac myocytes through activation of G protein, PKC and Rho signaling pathways. , 2011, Journal of molecular and cellular cardiology.
[62] Adrian Hernandez,et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. , 2009, American heart journal.
[63] Eoin Fahy,et al. Bioinformatics for lipidomics. , 2007, Methods in enzymology.